These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27885961)

  • 1. INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine.
    Koskinen S; Kampman O; Solismaa A; Lyytikäinen LP; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Mononen N; Lehtimäki T; Leinonen E
    Pharmacogenomics; 2016 Dec; 17(18):1987-1997. PubMed ID: 27885961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
    Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of the HTR2C, leptin and adiponectin genes and serum marker analyses in clozapine treated long-term patients with schizophrenia.
    Klemettilä JP; Kampman O; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Mononen N; Lehtimäki T; Leinonen E
    Eur Psychiatry; 2015 Feb; 30(2):296-302. PubMed ID: 25284335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
    Opgen-Rhein C; Brandl EJ; Müller DJ; Neuhaus AH; Tiwari AK; Sander T; Dettling M
    Pharmacogenomics; 2010 Jun; 11(6):773-80. PubMed ID: 20504252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.
    Tiwari AK; Zai CC; Meltzer HY; Lieberman JA; Müller DJ; Kennedy JL
    Hum Psychopharmacol; 2010 Apr; 25(3):253-9. PubMed ID: 20373477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions.
    Birkenaes AB; Birkeland KI; Engh JA; Faerden A; Jonsdottir H; Ringen PA; Friis S; Opjordsmoen S; Andreassen OA
    J Clin Psychopharmacol; 2008 Apr; 28(2):132-7. PubMed ID: 18344722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.
    Huang HH; Wang YC; Wu CL; Hong CJ; Bai YM; Tsai SJ; Liou YJ
    Neurosci Lett; 2011 Oct; 504(3):277-80. PubMed ID: 21967963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidemia and atypical antipsychotic drugs.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 18():27-35. PubMed ID: 15600382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
    Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
    Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics.
    Liou YJ; Bai YM; Lin E; Chen JY; Chen TT; Hong CJ; Tsai SJ
    Pharmacogenomics J; 2012 Feb; 12(1):54-61. PubMed ID: 20877301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
    Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
    Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of blood cell counts with the risk of olanzapine- or clozapine-induced dyslipidemia in Chinese schizophrenia patients.
    Xiong Z; Cheng M; Zhu P; Huang S; Guo J; Zhang W; Zhou H; Shu Y; Li Q
    Hum Psychopharmacol; 2019 Jul; 34(4):e2699. PubMed ID: 31273857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients.
    Solismaa A; Kampman O; Lyytikäinen LP; Seppälä N; Viikki M; Mononen N; Lehtimäki T; Leinonen E
    Eur Neuropsychopharmacol; 2017 May; 27(5):442-449. PubMed ID: 28400155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy.
    Huang TL; Lu CY
    Chang Gung Med J; 2007; 30(1):26-32. PubMed ID: 17477026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia.
    Chen PY; Huang MC; Chiu CC; Liu HC; Lu ML; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1927-32. PubMed ID: 21840365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia.
    Bai YM; Chen JY; Yang WS; Chi YC; Liou YJ; Lin CC; Wang YC; Lin CY; Su TP; Chou P
    J Clin Psychiatry; 2007 Dec; 68(12):1834-9. PubMed ID: 18162013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association between TNF-alpha -308 G>A polymorphism and longitudinal weight change during clozapine treatment.
    Wang YC; Bai YM; Chen JY; Lin CC; Lai IC; Liou YJ
    Hum Psychopharmacol; 2010; 25(4):303-9. PubMed ID: 20521320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
    Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
    Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.
    Ma X; Maimaitirexiati T; Zhang R; Gui X; Zhang W; Xu G; Hu G
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):229-42. PubMed ID: 25152019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain.
    Reynolds GP; Zhang Z; Zhang X
    Am J Psychiatry; 2003 Apr; 160(4):677-9. PubMed ID: 12668355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.